These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29408864)

  • 1. In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria.
    Larpin Y; Oechslin F; Moreillon P; Resch G; Entenza JM; Mancini S
    PLoS One; 2018; 13(2):e0192507. PubMed ID: 29408864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.
    Ma Q; Guo Z; Gao C; Zhu R; Wang S; Yu L; Qin W; Xia X; Gu J; Yan G; Lei L
    Antonie Van Leeuwenhoek; 2017 Mar; 110(3):347-355. PubMed ID: 27943012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad Bactericidal Activity of the
    Antonova NP; Vasina DV; Lendel AM; Usachev EV; Makarov VV; Gintsburg AL; Tkachuk AP; Gushchin VA
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30901901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.
    Yan G; Liu J; Ma Q; Zhu R; Guo Z; Gao C; Wang S; Yu L; Gu J; Hu D; Han W; Du R; Yang J; Lei L
    Antonie Van Leeuwenhoek; 2017 Dec; 110(12):1627-1635. PubMed ID: 28730370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic Antimicrobial Peptide Facilitates a New Broad-Spectrum Lysin LysP53 to Kill
    Li C; Jiang M; Khan FM; Zhao X; Wang G; Zhou W; Li J; Yu J; Li Y; Wei H; Yang H
    ACS Infect Dis; 2021 Dec; 7(12):3336-3344. PubMed ID: 34788533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii.
    Abdelkader K; Gutiérrez D; Tamés-Caunedo H; Ruas-Madiedo P; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
    Appl Environ Microbiol; 2022 Jan; 88(1):e0151521. PubMed ID: 34669452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Phage Lysin Abp013 against
    Chu JJK; Poh WH; Hasnuddin NTB; Hew EY; Dam LC; Sahili AE; Rice SA; Goh BC
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases.
    Matsuzaki S; Rashel M; Uchiyama J; Sakurai S; Ujihara T; Kuroda M; Ikeuchi M; Tani T; Fujieda M; Wakiguchi H; Imai S
    J Infect Chemother; 2005 Oct; 11(5):211-9. PubMed ID: 16258815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
    Heselpoth RD; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Delivery of Newly Identified Prophage Lysins in a
    Morais D; Tanoeiro L; Marques AT; Gonçalves T; Duarte A; Matos APA; Vital JS; Cruz MEM; Carvalheiro MC; Anes E; Vítor JMB; Gaspar MM; Vale FF
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077542
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt.
    Mohamed NM; Youssef AA
    Microb Drug Resist; 2011 Dec; 17(4):489-95. PubMed ID: 21875338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity and mechanism of action of copper-sputtered flexible surfaces against multidrug-resistant pathogens.
    Ballo MK; Rtimi S; Mancini S; Kiwi J; Pulgarin C; Entenza JM; Bizzini A
    Appl Microbiol Biotechnol; 2016 Jul; 100(13):5945-53. PubMed ID: 27020284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.
    Lood R; Winer BY; Pelzek AJ; Diez-Martinez R; Thandar M; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1983-91. PubMed ID: 25605353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Yang H; Wang M; Yu J; Wei H
    Front Microbiol; 2015; 6():1471. PubMed ID: 26733995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.
    Lai MJ; Lin NT; Hu A; Soo PC; Chen LK; Chen LH; Chang KC
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):529-39. PubMed ID: 21264466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoinactivation of Gram positive and Gram negative bacteria with the antimicrobial peptide (KLAKLAK)(2) conjugated to the hydrophilic photosensitizer eosin Y.
    Johnson GA; Muthukrishnan N; Pellois JP
    Bioconjug Chem; 2013 Jan; 24(1):114-23. PubMed ID: 23240991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological characterization of the phage lysin AVPL and its efficiency against
    Xi H; Ji Y; Fu Y; Chen C; Han W; Gu J
    Appl Environ Microbiol; 2024 Aug; 90(8):e0046124. PubMed ID: 39012099
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual antibacterial mechanisms of nisin Z against Gram-positive and Gram-negative bacteria.
    Kuwano K; Tanaka N; Shimizu T; Nagatoshi K; Nou S; Sonomoto K
    Int J Antimicrob Agents; 2005 Nov; 26(5):396-402. PubMed ID: 16226432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion.
    Liu P; Dong X; Cao X; Xie Q; Huang X; Jiang J; Dai H; Tang Z; Lin Y; Feng S; Luo K
    Microbiol Spectr; 2023 Feb; 11(2):e0451522. PubMed ID: 36749047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.